Lucio G. Costa

Personal Home Page

http://depts.washington.edu/envhlth/faculty.php?Costa_Lucio

Articles in Scholarly Journals [Incomplete List]

  1. Developmental neurotoxicity of polybrominated diphenyl ether (PBDE) flame retardants
    NeuroToxicology, vol. 28, no. 6, pp. 1047–1067, 2007
  2. Organophosphorus insecticides chlorpyrifos and diazinon and oxidative stress in neuronal cells in a genetic model of glutathione deficiency
    Toxicology and Applied Pharmacology, vol. 219, no. 2-3, pp. 181–189, 2007
  3. An in vitro approach to assess the toxicity of certain food contaminants: Methylmercury and polychlorinated biphenyls
    Toxicology, vol. 237, no. 1-3, pp. 65–76, 2007
  4. Ethanol Induces Cholesterol Efflux and Up-regulates ATP-binding Cassette Cholesterol Transporters in Fetal Astrocytes
    Journal of Biological Chemistry, vol. 282, no. 26, pp. 18740–18749, 2007
  5. Zagađivala U Ribama: Razmatranja Rizika I Dobrobiti
    Archives of Industrial Hygiene and Toxicology, vol. 58, no. 3, pp. 367–374, 2007
  6. 5' and 3' region variability in the dopamine transporter gene (SLC6A3), pesticide exposure and Parkinson's disease risk: a hypothesis-generating study
    Human Molecular Genetics, vol. 15, no. 20, pp. 3055–3062, 2006
  7. Neurotoxicity of Domoic Acid in Cerebellar Granule Neurons in a Genetic Model of Glutathione Deficiency
    Molecular Pharmacology, vol. 70, no. 6, pp. 2116–2126, 2006
  8. Current issues in organophosphate toxicology
    Clinica Chimica Acta, vol. 366, no. 1-2, pp. 1–13, 2006
  9. Measurement of paraoxonase (PON1) status as a potential biomarker of susceptibility to organophosphate toxicity
    Clinica Chimica Acta, vol. 352, no. 1-2, pp. 37–47, 2005
  10. Diet–brain connections: role of neurotoxicants
    Environmental Toxicology and Pharmacology, vol. 19, no. 3, pp. 395–400, 2005
  11. Disruption of cholesterol homeostasis in the developing brain as a potential mechanism contributing to the developmental neurotoxicity of ethanol: an hypothesis
    Medical Hypotheses, vol. 64, no. 3, pp. 563–567, 2005
  12. Characterization of the in vitro transcriptional activity of polymorphic alleles of the human monoamine oxidase-B gene
    Neuroscience Letters, vol. 383, no. 1-2, pp. 171–175, 2005
  13. Genotype combinations for monoamine oxidase-B intron 13 polymorphism and dopamine D2 receptor TaqIB polymorphism are associated with ever-smoking status among men
    Neuroscience Letters, vol. 385, no. 2, pp. 158–162, 2005
  14. Role of Paraoxonase (PON1) Status in Pesticide Sensitivity: Genetic and Temporal Determinants
    NeuroToxicology, vol. 26, no. 4, pp. 651–659, 2005
  15. Early Developmental Exposure to BDE 99 or Aroclor 1254 Affects Neurobehavioural Profile: Interference from the Administration Route
    NeuroToxicology, vol. 26, no. 2, pp. 183–192, 2005
  16. Effect of organophosphorus insecticides and their metabolites on astroglial cell proliferation
    Toxicology, vol. 215, no. 3, pp. 182–190, 2005
  17. Modulation of paraoxonase (PON1) activity
    Biochemical Pharmacology, vol. 69, no. 4, pp. 541–550, 2005
  18. Chronic exposure to ammonia induces isoform-selective alterations in the intracellular distribution and NMDA receptor-mediated translocation of protein kinase C in cerebellar neurons in culture
    Journal of Neurochemistry, vol. 92, no. 1, pp. 143–157, 2005
  19. Activation of NMDA receptors induces protein kinase A-mediated phosphorylation and degradation of matrin 3. Blocking these effects prevents NMDA-induced neuronal death
    Journal of Neurochemistry, vol. 94, no. 3, pp. 808–818, 2005
  20. NTP-CERHR Expert Panel Report on the reproductive and developmental toxicity of amphetamine and methamphetamine
    Birth Defects Research Part B: Developmental and Reproductive Toxicology, vol. 74, no. 6, pp. 471–584, 2005
  21. NTP-CERHR Expert Panel Report on the reproductive and developmental toxicity of methylphenidate
    Birth Defects Research Part B: Developmental and Reproductive Toxicology, vol. 74, no. 4, pp. 300–381, 2005
  22. Paraoxonase 1 (PON1) status and risk of insecticide exposure
    Journal of Biochemical and Molecular Toxicology, vol. 19, no. 3, pp. 182–183, 2005
  23. DNA sequence analysis of monoamine oxidase B gene coding and promoter regions in Parkinson's disease cases and unrelated controls
    Movement Disorders, vol. 19, no. 1, pp. 76–83, 2004
  24. Paraoxonase 2 (PON2) polymorphisms and Parkinson's disease
    Neuroscience Research Communications, vol. 34, no. 3, pp. 130–135, 2004
  25. Structural Effects and Neurofunctional Sequelae of Developmental Exposure to Psychotherapeutic Drugs: Experimental and Clinical Aspects
    Pharmacological Reviews, vol. 56, no. 1, pp. 103–147, 2004
  26. DEVELOPMENTAL NEUROPATHOLOGY OF ENVIRONMENTAL AGENTS
    Annual Review of Pharmacology and Toxicology, vol. 44, no. 1, pp. 87–110, 2004
  27. Role of phospholipase D signaling in ethanol-induced inhibition of carbachol-stimulated DNA synthesis of 1321N1 astrocytoma cells
    Journal of Neurochemistry, vol. 90, no. 3, pp. 646–653, 2004
  28. Involvement of glial cells in the neurotoxicity of parathion and chlorpyrifos
    Toxicology and Applied Pharmacology, vol. 201, no. 2, pp. 97–104, 2004
  29. Signal transduction mechanisms involved in the antiproliferative effects of ethanol in glial cells
    Toxicology Letters, vol. 149, no. 1-3, pp. 67–73, 2004
  30. Differential in vitro neurotoxicity of the flame retardant PBDE-99 and of the PCB Aroclor 1254 in human astrocytoma cells
    Toxicology Letters, vol. 154, no. 1-2, pp. 11–21, 2004
  31. Polybrominated Diphenyl Ethers: Neurobehavioral Effects Following Developmental Exposure
    NeuroToxicology, vol. 24, no. 3, pp. 449–462, 2003
  32. Nuclear factor ?b activation by muscarinic receptors in astroglial cells: effect of ethanol
    Neuroscience, vol. 120, no. 4, pp. 941–950, 2003
  33. Ethanol inhibits muscarinic receptor-mediated DNA synthesis and signal transduction in human fetal astrocytes
    Neuroscience Letters, vol. 344, no. 1, pp. 68–70, 2003
  34. EVALUATION OF BROMINATED DIPHENYL ETHER-99 TOXICITY WITH RAPHIDOCELIS SUBCAPITATA AND DAPHNIA MAGNA
    Environmental Toxicology and Chemistry, vol. 22, no. 9, p. 2167, 2003
  35. Paraoxonase 1 promoter and coding region polymorphisms in Parkinson's disease
    Journal of Neurology, Neurosurgery & Psychiatry, vol. 74, no. 4, pp. 546–547, 2003
  36. FUNCTIONAL GENOMICS OF THE PARAOXONASE (PON1) POLYMORPHISMS: Effects on Pesticide Sensitivity, Cardiovascular Disease, and Drug Metabolism
    Annual Review of Medicine, vol. 54, no. 1, pp. 371–392, 2003
  37. Developmental Neurotoxicity of Toluene: in vivo and in vitro Effects on Astroglial Cells
    Developmental Neuroscience, vol. 25, no. 1, pp. 14–19, 2003
  38. Characterization of the Effect of Epilobium Extracts on Human Cell Proliferation
    Pharmacology, vol. 69, no. 2, pp. 79–87, 2003
  39. Extracts of various species of Epilobium inhibit proliferation of human prostate cells
    Journal of Pharmacy and Pharmacology, vol. 55, no. 5, pp. 683–690, 2003
  40. Pharmacogenetics, vol. 13, no. 6, pp. 357–364, 2003
  41. In vivo ethanol decreases phosphorylated MAPK and p70S6 kinase in the developing rat brain
    NeuroReport, vol. 14, no. 10, pp. 1395–1399, 2003
  42. Paraoxonase (PON 1) as a biomarker of susceptibility for organophosphate toxicity
    Biomarkers, vol. 8, no. 1, pp. 1–12, 2003
  43. Polymorphisms of Paraoxonase (PON1) and Their Significance in Clinical Toxicology of Organophosphates
    Clinical Toxicology, vol. 41, no. 1, pp. 37–45, 2003
  44. In vitro assessment of mutagenicity and clastogenicity of BDE-99, a pentabrominated diphenyl ether flame retardant
    Environmental and Molecular Mutagenesis, vol. 42, no. 2, pp. 85–90, 2003
  45. Effect of ethanol on protein kinase Czeta and p70S6 kinase activation by carbachol: a possible mechanism for ethanol-induced inhibition of glial cell proliferation
    Journal of Neurochemistry, vol. 82, no. 1, pp. 38–46, 2002
  46. Inorganic Lead Activates the Mitogen-Activated Protein Kinase Kinase-Mitogen-Activated Protein Kinase-p90RSK Signaling Pathway in Human Astrocytoma Cells via a Protein Kinase C-Dependent Mechanism
    Journal of Pharmacology and Experimental Therapeutics, vol. 300, no. 3, pp. 818–823, 2002
  47. Pharmacogenomic considerations of the paraoxonase polymorphisms
    Pharmacogenomics, vol. 3, no. 3, pp. 341–348, 2002
  48. Developmental neurotoxicity: do similar phenotypes indicate a common mode of action? A comparison of fetal alcohol syndrome, toluene embryopathy and maternal phenylketonuria
    Toxicology Letters, vol. 127, no. 1-3, pp. 197–205, 2002
  49. Inhibition of Muscarinic Receptor-Induced Proliferation of Astroglial Cells by Ethanol: Mechanisms and Implications for the Fetal Alcohol Syndrome
    NeuroToxicology, vol. 23, no. 6, pp. 685–691, 2002
  50. Gender Difference in the Interaction of Smoking and Monoamine Oxidase B Intron 13 Genotype in Parkinson's Disease
    NeuroToxicology, vol. 23, no. 4-5, pp. 515–519, 2002
  51. Effects of Perinatal Exposure to a Polybrominated Diphenyl Ether (PBDE 99) on Mouse Neurobehavioural Development
    NeuroToxicology, vol. 23, no. 3, pp. 375–384, 2002
  52. Inorganic lead stimulates DNA synthesis in human astrocytoma cells: role of protein kinase Calpha
    Journal of Neurochemistry, vol. 78, no. 3, pp. 590–599, 2001
  53. Activation of phosphatidylinositol 3 kinase by muscarinic receptors in astrocytoma cells
    Neuroreport, vol. 12, no. 8, pp. 1639–1642, 2001
  54. Activation of mitogen-activated protein kinase by muscarinic receptors in astroglial cells: Role in DNA synthesis and effect of ethanol
    Glia, vol. 35, no. 2, pp. 111–120, 2001
  55. Effect of ethanol on muscarinic receptor-induced calcium responses in astroglia
    Journal of Neuroscience Research, vol. 60, no. 3, pp. 345–355, 2000
  56. Muscarinic receptor-induced calcium responses in astroglia
    Cytometry, vol. 41, no. 2, pp. 123–132, 2000
  57. Exposure to 60-Hz Magnetic Fields and Proliferation of Human Astrocytoma Cells in Vitro
    Toxicology and Applied Pharmacology, vol. 162, no. 3, pp. 166–176, 2000
  58. Maturation-Dependent Effects of Chlorpyrifos and Parathion and Their Oxygen Analogs on Acetylcholinesterase and Neuronal and Glial Markers in Aggregating Brain Cell Cultures
    Toxicology and Applied Pharmacology, vol. 165, no. 3, pp. 175–183, 2000
  59. Pharmacogenetics, vol. 10, no. 9, pp. 767–779, 2000
  60. Genetic polymorphism of dopamine D2 receptors in Parkinson's disease and interactions with cigarette smoking and MAO-B intron 13 polymorphism
    Journal of Neurology, Neurosurgery & Psychiatry, vol. 69, no. 4, pp. 535–537, 2000
  61. Sheldon D. Murphy
    Toxicological Sciences, vol. 57, no. 2, pp. 191–192, 2000
  62. The EcoRV genetic polymorphism of human monoamine oxidase type A is not associated with Parkinson's disease and does not modify the effect of smoking on Parkinson's disease
    Neuroscience Letters, vol. 278, no. 1-2, pp. 33–36, 2000
  63. Possible role of protein kinase C ? in muscarinic receptor-induced proliferation of astrocytoma cells
    Biochemical Pharmacology, vol. 60, no. 10, pp. 1457–1466, 2000
  64. Muscarinic cholinergic receptor signal transduction as a potential target for the developmental neurotoxicity of ethanol
    Biochemical Pharmacology, vol. 57, no. 7, pp. 721–726, 1999
  65. Effects of ethanol on calcium homeostasis in the nervous system
    Molecular Neurobiology, vol. 19, no. 1, pp. 1–24, 1999
  66. Effect of subchronic ethanol ingestion on styrene-induced damage to the tracheal and pulmonary epithelium of the rat
    Journal of Applied Toxicology, vol. 18, no. 5, pp. 349–356, 1998
  67. The role of protein kinase C a and ? isozymes in DNA synthesis induced by muscarinic receptors in a glial cell line
    European Journal of Pharmacology, vol. 359, no. 2-3, pp. 223–233, 1998
  68. Ethanol selectively interferes with the trophic action of NMDA and carbachol on cultured cerebellar granule neurons undergoing apoptosis
    Developmental Brain Research, vol. 111, no. 2, pp. 279–289, 1998
  69. Nature, vol. 394, no. 6690, pp. 284–287, 1998
  70. Biochemical and molecular neurotoxicology: relevance to biomarker development, neurotoxicity testing and risk assessment
    Toxicology Letters, vol. 102-103, no. 1-2, pp. 417–421, 1998
  71. EFFECTS OF ETHANOL ON GLIAL CELL PROLIFERATION: RELEVANCE TO THE FETAL ALCOHOL SYNDROME
    Pediatric Pathology & Molecular Medicine, vol. 18, no. 4-5, pp. 433–443, 1998
  72. Paraoxonase (Pon1) gene in mice: sequencing, chromosomal localization and developmental expression
    Pharmacogenetics, vol. 7, no. 2, pp. 137–144, 1997
  73. Xestospongins: Potent Membrane Permeable Blockers of the Inositol 1,4,5-Trisphosphate Receptor
    Neuron, vol. 19, no. 3, pp. 723–733, 1997
  74. Association of a polymorphism in intron 13 of the monoamine oxidase B gene with Parkinson disease
    American Journal of Medical Genetics, vol. 74, no. 2, pp. 154–156, 1997
  75. Urinary mercapturic acid diastereoisomers in rats subchronically exposed to styrene and ethanol
    Archives of Toxicology, vol. 70, no. 11, pp. 736–741, 1996
  76. Acetylcholine as a mitogen: muscarinic receptor-mediated proliferation of rat astrocytes and human astrocytoma cells
    European Journal of Pharmacology, vol. 297, no. 3, pp. 265–273, 1996
  77. Effects of ethanol administration on cerebral non-protein sulfhydryl content in rats exposed to styrene vapour
    Toxicology, vol. 106, no. 1-3, pp. 115–122, 1996
  78. Evaluation of the neurotoxicity of glycidamide, an epoxide metabolite of acrylamide: behavioral, neurochemical and morphological studies
    Toxicology, vol. 98, no. 1-3, pp. 151–161, 1995
  79. Biochemical markers of neurotoxicity: research strategies and epidemiological applications
    Toxicology Letters, vol. 77, no. 1-3, pp. 137–144, 1995
  80. Paraoxonase protects against chlorpyrifos toxicity in mice
    Toxicology Letters, vol. 76, no. 3, pp. 219–226, 1995
  81. Heterogeneity of cholinergic muscarinic receptors coupled to phosphoinositide metabolism in immature rat brain
    Developmental Brain Research, vol. 86, no. 1-2, pp. 134–142, 1995
  82. Postnatal development of muscarinic receptor-stimulated phosphoinositide metabolism in mouse cerebral cortex: sensitivity to ethanol
    Developmental Brain Research, vol. 86, no. 1-2, pp. 348–353, 1995
  83. Interaction of ethanol and anoxia with muscarinic receptor-stimulated phosphoinositide metabolism during brain development
    Life Sciences, vol. 57, no. 18, pp. 1667–1673, 1995
  84. Long-lasting microencephaly following exposure to cocaine during the brain growth spurt in the rat
    Developmental Brain Research, vol. 84, no. 2, pp. 179–184, 1995
  85. Inhibition of muscarinic receptor-stimulated phosphoinositide metabolism by cocaine, norcocaine and cocaethylene in rat brain
    Developmental Brain Research, vol. 79, no. 1, pp. 132–135, 1994
  86. Expression of cholinergic muscarinic receptor subtypes mRNA in rat blood mononuclear cells
    Immunopharmacology, vol. 28, no. 2, pp. 113–123, 1994
  87. Lack of m2 muscarinic acetylcholine receptor mRNA in rat lymphocytes
    Journal of Neuroimmunology, vol. 49, no. 1-2, pp. 115–124, 1994
  88. Relationships between Biomarkers of Exposure and Neurological Effects in a Group of Workers Exposed to Acrylamide
    Toxicology and Applied Pharmacology, vol. 126, no. 2, pp. 361–371, 1994
  89. Effects of Styrene Oxide on Differentiation and Viability of Rodent Embryo Cultures
    Toxicology and Applied Pharmacology, vol. 128, no. 1, pp. 25–35, 1994
  90. Developmental neurotoxicity of ethanol: further evidence for an involvement of muscarinic receptor-stimulated phosphoinositide hydrolysis
    European Journal of Pharmacology: Molecular Pharmacology, vol. 266, no. 3, pp. 283–289, 1994
  91. Interaction of the neurotoxic pesticides ivermectin and lindane with the enteric GABAA receptor-ionophore complex in the guinea-pig
    European Journal of Pharmacology: Environmental Toxicology and Pharmacology, vol. 248, no. 1, pp. 1–6, 1993
  92. Cyclic GMP formation induced by muscarinic receptors is mediated by nitric oxide synthesis in rat cortical primary cultures
    Brain Research, vol. 610, no. 1, pp. 57–61, 1993
  93. Human and rabbit paraoxonases: Purification, cloning, sequencing, mapping and role of polymorphism in organophosphate detoxification
    Chemico-Biological Interactions, vol. 87, no. 1-3, pp. 35–48, 1993
  94. Modulation of Muscarinic Receptors and Acetylcholinesterase Activity in Lymphocytes and in Brain Areas Following Repeated Organophosphate Exposure in Rats
    Fundamental and Applied Toxicology, vol. 20, no. 2, pp. 210–216, 1993
  95. Interaction of ethanol with muscarinic receptor-stimulated phosphoinositide metabolism during the brain growth spurt in the rat: role of acetaldehyde
    Neuroscience Letters, vol. 156, no. 1-2, pp. 13–16, 1993
  96. Lymphocyte $beta;-adrenoceptors, asthma, and ethnicity
    The Lancet, vol. 340, no. 8821, p. 738, 1992
  97. Peripheral blood cell activities of monoamine oxidase B and superoxide dismutase in Parkinson's disease
    Journal of Neural Transmission - Parkinson's Disease and Dementia Section, vol. 4, no. 4, pp. 283–290, 1992
  98. Two subtypes of enteric non-opioid s receptors in guinea-pig cholinergic motor neurons
    European Journal of Pharmacology, vol. 198, no. 1, pp. 105–108, 1991
  99. 3H-spiperone labels sigma receptors, not dopamine D2 receptors, in rat and human lymphocytes
    Immunopharmacology, vol. 22, no. 2, pp. 93–105, 1991
  100. Chemical Research in Toxicology, vol. 3, no. 5, pp. 406–412, 1990
  101. Formamidine pesticides and alpha2-adrenoceptors: Studies with amitraz and chlordimeform in rats and development of a radioreceptor binding assay
    Neurotoxicology and Teratology, vol. 11, no. 4, pp. 405–411, 1989
  102. Acute and chronic effects of the pesticide amitraz on a2-adrenoceptors in the mouse brain
    Toxicology Letters, vol. 47, no. 2, pp. 135–143, 1989
  103. Spectrophotometric assays for the enzymatic hydrolysis of the active metabolites of chlorpyrifos and parathion by plasma paraoxonase/arylesterase
    Analytical Biochemistry, vol. 180, no. 2, pp. 242–247, 1989
  104. Behavioral and biochemical effects of postnatal parathion exposure in the rat
    Neurotoxicology and Teratology, vol. 10, no. 3, pp. 261–266, 1988
  105. Spatial memory impairment and central muscarinic receptor loss following prolonged treatment with organophosphates,
    Toxicology Letters, vol. 40, no. 1, pp. 47–56, 1988
  106. Interactions of neurotoxicants with neurotransmitter systems
    Toxicology, vol. 49, no. 2-3, pp. 359–366, 1988
  107. Muscarinic cholinergic binding sites on rat lymphocytes
    Immunopharmacology, vol. 16, no. 3, pp. 139–149, 1988
  108. Alpha2-adrenoceptors as a target for formamidine pesticides: In vitro and in vivo studies in mice
    Toxicology and Applied Pharmacology, vol. 93, no. 2, pp. 319–328, 1988
  109. Effects of trimethyltin on granule cells excitability in the in Vitro rat dentate gyrus
    Neurotoxicology and Teratology, vol. 9, no. 1, pp. 33–38, 1987
  110. Interaction of the pesticide chlordimeform with adrenergic receptors in mouse brain: an in vitro study
    Archives of Toxicology, vol. 59, no. 5, pp. 323–327, 1987
  111. Interaction of choline with muscarine receptor-stimulated phosphoinositide metabolism in the rat brain
    Naunyn-Schmiedeberg's Archives of Pharmacology, vol. 334, no. 4, pp. 536–539, 1986
  112. Effect of diethylmaleate and other glutathione depletors on protein synthesis
    Biochemical Pharmacology, vol. 35, no. 19, pp. 3383–3388, 1986
  113. Cholinergic and opiate involvement in the antinociceptive effect of diisopropylfluorophosphate
    Pharmacology Biochemistry and Behavior, vol. 24, no. 3, pp. 733–736, 1986
  114. Conditioned taste aversion induced by organophosphate compounds in rats
    Pharmacology Biochemistry and Behavior, vol. 24, no. 3, pp. 737–742, 1986
  115. Inhibition of protein synthesis by trimethyltin
    Toxicology and Applied Pharmacology, vol. 86, no. 2, pp. 189–196, 1986
  116. Inhibition of ?-63H9aminobutyric acid uptake by organotin compounds in vitro
    Toxicology and Applied Pharmacology, vol. 79, no. 3, pp. 471–479, 1985
  117. A comparison of the antinociceptive responses to the GABA-receptor agonists THIP and baclofen
    Neuropharmacology, vol. 24, no. 3, pp. 211–216, 1985
  118. Characterization of muscarinic cholinergic receptors in the submandibular gland of the rat
    Journal of the Autonomic Nervous System, vol. 13, no. 4, pp. 287–301, 1985
  119. Chronic administration of an organophosphorus insecticide to rats alters cholinergic muscarinic receptors in the pancreas
    Chemico-Biological Interactions, vol. 48, no. 3, pp. 261–269, 1984
  120. INTERACTION OF CHOLINE WITH NICOTINIC AND MUSCARINIC CHOLINERGIC RECEPTORS IN THE RAT BRAIN IN VITRO
    Clinical and Experimental Pharmacology and Physiology, vol. 11, no. 6, pp. 649–654, 1984
  121. Unidirectional cross-tolerance between the carbamate insecticide propoxur and the organophosphate disulfoton in mice
    Fundamental and Applied Toxicology, vol. 3, no. 5, pp. 483–488, 1983
  122. A selective decrease of cholinergic muscarinic receptors in the visual cortex of adult rats following developmental lead exposure
    Brain Research, vol. 276, no. 2, pp. 259–266, 1983
  123. Muscarinic receptor alterations as a mechanism of anticholinesterase tolerance*1
    Toxicology and Applied Pharmacology, vol. 71, no. 1, pp. 14–23, 1983
  124. Antinociceptive and hypothermic effects of trimethyltin
    Life Sciences, vol. 31, no. 11, pp. 1093–1102, 1982
  125. Factors involved in the differential acute toxicity of the insecticides chlorpyrifos and methyl chlopyrifos in mice*1, *2
    Toxicology and Applied Pharmacology, vol. 65, no. 1, pp. 144–152, 1982
  126. Passive avoidance retention in mice tolerant to the organophosphorus insecticide disulfoton
    Toxicology and Applied Pharmacology, vol. 65, no. 3, pp. 451–458, 1982
  127. Transvaginal absorption and disposition of nonoxynol-9 in gravid rats
    Toxicology Letters, vol. 13, no. 3-4, pp. 217–223, 1982
  128. Tolerance to anticholinesterase compounds in mammals
    Toxicology, vol. 25, no. 2-3, pp. 79–97, 1982
  129. Trimethyltin inhibits uptake of neurotransmitters into mouse forebrain synaptosomes
    Toxicology, vol. 25, no. 2-3, pp. 213–221, 1982
  130. Differential alterations of cholinergic muscarinic receptors during chronic and acute tolerance to organophosphorus insecticides
    Biochemical Pharmacology, vol. 31, no. 21, pp. 3407–3413, 1982
  131. Muscarinic receptor alterations following neostigmine treatment
    European Journal of Pharmacology, vol. 80, no. 2-3, pp. 275–278, 1982
  132. Decreased muscarinic binding sites in small intestine from mice treated with neostigmine
    Life Sciences, vol. 29, no. 16, pp. 1675–1682, 1981
  133. Tolerance to the carbamate insecticide propoxur,
    Toxicology, vol. 21, no. 4, pp. 267–278, 1981
  134. Reduced 63H9quinuclidinyl benzilate binding to muscarinic receptors in disulfoton-tolerant mice*1
    Toxicology and Applied Pharmacology, vol. 60, no. 3, pp. 441–450, 1981